CytomX Therapeutics, Inc. (CTMX)

CytomX Therapeutics Revenue

CytomX Therapeutics had revenue of $10.26M in the quarter ending March 31, 2026, a decrease of -79.85%. This brings the company's revenue in the last twelve months to $35.54M, down -75.91% year-over-year. In the year 2025, CytomX Therapeutics had annual revenue of $76.20M, down -44.82%.

• Revenue (ttm): $35.54M
• Revenue Growth: -75.91%
• P/S Ratio: 23.18
• Revenue / Employee: $515,101
• Employees: 69
• Market Cap: 785.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	76.20M	-61.90M	-44.82%
Dec 31, 2024	138.10M	36.89M	36.45%
Dec 31, 2023	101.21M	48.05M	90.38%
Dec 31, 2022	53.16M	15.85M	42.48%
Dec 31, 2021	37.31M	-31.12M	-45.47%
Dec 31, 2020	68.43M	41.53M	154.36%
Dec 31, 2019	26.90M	-32.60M	-54.79%
Dec 31, 2018	59.50M	-12.12M	-16.92%
Dec 31, 2017	71.62M	58.78M	457.59%
Dec 31, 2016	12.85M	6.90M	116.21%
Dec 31, 2015	5.94M	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	888.00K	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error